Biotech

All Articles

8 months after a $213M fundraise, genetics publisher Volume creates reduces

.After bring up $213 million in 2023-- among the year's largest private biotech shots-- Tome Bioscie...

BioMarin creates exec group with biotech vets-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of notable management hirings, firings and ...

Biopharma Q2 VC reached highest level considering that '22, while M&ampA slowed down

.Equity capital backing into biopharma rose to $9.2 billion throughout 215 sell the 2nd quarter of t...

Bicara, Zenas find IPOs to press late-phase possessions toward market

.Bicara Therapeutics and also Zenas Biopharma have supplied fresh catalyst to the IPO market with fi...

Genentech to close cancer cells immunology research team

.Genentech will shut its own cancer cells immunology study team, and unit mind and also distinguishe...

Kezar goes down solid tumor yet to prove its really worth in period 1 trial

.Kezar Life Sciences is actually losing its own unpromising phase 1 solid tumor medication as the bi...

Acelyrin falls izokibep, drops 3rd of workers

.Despite izokibep sustaining its newly found winning touch in the medical clinic, Acelyrin is no lon...

Rivus' phase 2 obesity-related heart failure trial attacks endpoint

.Rivus Pharmaceuticals has actually plumped up the leads of its fat-busting, muscle-sparing drug app...

Ovid stops preclinical job, IV course after soticlestat neglect

.Ovid Therapeutics presently exposed final month that it was actually trimming back its headcount as...

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston Port

.Eli Lilly has actually opened up a $700 thousand R&ampD facility in the Boston Seaport, boosting it...